News & Events

Contacts:

Investor Relations
703.742.5393
InvestorRelations@quadramed.com

Brooke Kane
Marketing Manager
703.989.7020
press@quadramed.com

 

Reston, VA — March 23, 2009 —

RESTON, Va.--(BUSINESS WIRE)--Mar. 23, 2009-- QuadraMed (NASDAQ: QDHC) today announced that Fremont-Rideout Health Group (FRHG) chose QuadraMed Revenue Cycle and Quantim® Health Information Management (HIM) solutions to streamline their revenue collection process, improve clinical workflow, and leverage business intelligence and real-time reporting to help maximize operational efficiencies.

“After an in-depth evaluation of existing and new vendors, we selected the clear market leader in revenue cycle management and HIM -- QuadraMed,” said Tarun K. Ghosh, CIO at FRHG, a not-for-profit health system based in Yuba City and Marysville, Calif., which includes three acute care hospitals. “We determined that QuadraMed was the only vendor offering a scalable, integrated revenue cycle package that met our needs and requirements of our patient access, health information management and patient accounting departments.”

FRHG will begin deployment of the QuadraMed Revenue Cycle and Quantim solution suites this month and plans to “go live” in July 2010. The QuadraMed systems will replace existing applications from Allscripts-Misys Healthcare Solutions, Inc. and 3M Health Care.

Added Ghosh, “QuadraMed’s robust, high-performance revenue cycle and health information management systems provide us with the tools to effectively address reimbursement challenges while supporting our growing investment in electronic medical records. Together, these solutions help enable us to deliver an even higher level of patient- and community-centered care while achieving strong financial performance.”

FRHG also chose QuadraMed because its solutions uniquely feature a built-in encoder. “The built-in encoder spares us from having to buy, support and interface a separate application, which would have been the case had we selected another vendor,” Ghosh added.

“Consistently recognized for its clinical excellence, FRHG leverages the best technology and services in the market to further enhance their high-quality care and patient experience,” said Keith Hagen, QuadraMed’s president and CEO. “This client win validates QuadraMed's strong position in the revenue cycle and HIM market as we continue to invest in and develop the industry’s most advanced solutions, enabling hospitals and health systems to transform quality care into positive financial outcomes.”

About Fremont-Rideout Health Group

Fremont-Rideout Health Group (FRHG) is a not-for-profit health system dedicated to providing exceptional quality healthcare and a healing environment for everyone in its community. The health system, which is headquartered in Yuba City and Marysville, Calif., includes three acute care hospitals, three extended care facilities, a surgical center, home health, hospice and occupational health clinics. For more information about FRHG, please visit http://frhg.org/

About QuadraMed Corporation

QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. QuadraMed provides real world solutions that help healthcare professionals deliver outstanding patient care efficiently and cost effectively. Behind the company's products and services is a staff of 600 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com/

Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed’s actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed’s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC’s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).

QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.

Source: QuadraMed Corporation

###